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Abstract
The major objectives of the CHANGE PAIN International Advisory Board are to enhance understanding of
chronic pain and to develop strategies for improving pain management. At its second meeting, in November
2009, evidence was presented that around one person in five in Europe and the USA experiences chronic
pain, and the delay before referral to a pain specialist is often several years. Moreover, physicians’
pharmacological approach to chronic pain is inconsistent, as evidenced by the huge variation in
treatment between different European countries. It was agreed that efficient communication between
physician and patient is essential for effective pain management, and that efficacy/side-effect balance is
a key factor in choosing an analgesic agent. The multifactorial nature of chronic pain produces various
physical and psychological symptoms, so the management of chronic pain should be tailored to the
individual. Pharmacological therapy must be matched to the causative mechanisms responsible, or it is
likely to prove ineffective and risk the development of a ‘vicious circle’; doses are increased because of
inadequate pain relief, but this increases side-effects so doses are reduced, pain relief is then inadequate,
so doses are increased, and so on. Pain management decisions should not therefore be based solely on the
severity of pain. Based on the concept of individual treatment targets (ITT), the CHANGE PAIN Scale was
adopted – a simple, user-friendly assessment tool to improve communication between physician and
patient. The 11-point NRS enables the patient to rate the current pain intensity and to set a realistic
individual target level. On the reverse are six key parameters affecting the patient’s quality of life;
clinicians simply need to agree with patients whether improvement is needed in each one. Regular use
can establish the efficacy and tolerability of pain management, and the rate of progress towards individual
treatment targets.
Introduction
Epidemiological evidence indicates that a substantial proportion of adults in
Europe and the USA suffer from chronic pain that seriously affects the quality
of their social and working lives – and its inadequate management constitutes
a major healthcare problem1–4. Furthermore, the impact of chronic pain on
national economies and healthcare resources can be considerable5,6. In
November 2009, the international CHANGE PAIN consensus group of pain
specialists met for the second time in Zurich. In addition to considering the
reasons for inadequate pain management and discussing possible solutions, they
evaluated a new approach aimed at improving communication between health-
care professionals and patients suffering from chronic pain. One objective is to
optimise pharmacological treatment outcomes by moving the emphasis in pain
management from symptom control to mechanism-orientated treatment.
Objectives of the CHANGE PAIN group
The wider aims of the CHANGE PAIN group are to enhance understanding of
the needs of patients with chronic pain, and to develop strategies which will
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improve pain management. Important measures necessary to achieving such
improvement have been identified: the consensus group is committed to sup-
porting research that will provide a better understanding of physicians’ and
patients’ perspectives, to publishing study results, and to contributing to the
education of healthcare professionals. This will ultimately increase the knowl-
edge of pain mechanisms and facilitate treatment decisions7.
Prevalence and impact of chronic pain
Chronic pain has a considerable effect on patients’ quality of life, severely affect-
ing their sleep, ability to exercise, walk, perform household chores, attend social
activities and maintain an independent lifestyle1. In order to improve treatment
outcomes, it is important for healthcare professionals to appreciate the wider
implications of chronic pain. Data regarding these aspects of chronic pain in
Europe are available, particularly at a national level, but there are only a few
pan-European sources. A telephone survey of 46 394 respondents in 15 European
countries and Israel found that 19% of adults experienced moderate to severe
chronic pain (5 on a 10-point Numeric Rating Scale; NRS; 1¼no pain and
10¼worst pain imaginable)1. Approximately 20% of chronic pain sufferers said
their doctor had never asked about their pain. Around half of these patients had
constant pain, in approximately 20% of cases the pain had persisted for 20 years
or more, and 40% felt their pain was inadequately managed, but only 2% of 4839
respondents who underwent in-depth interviews were currently being treated by
a pain specialist1.
Similar results have been obtained by studies in individual countries. For
example, Sjøgren et al. concluded that 20.2% of the adult Danish population
suffer from chronic pain, and more than one-third of sufferers are dissatisfied
with the examinations made and the treatment offered2. A postal survey of 4000
adults in Norway found the prevalence of chronic pain to be 24.2% and that in
65% of cases it had been present for more than 5 years3.
Current treatment of chronic pain
A study in Germany found that the average time from onset of pain until the first
consultation with a general practitioner was 3 years, and until referral to a
specialised pain centre was 12 years8. In 47% of these cases referral was at the
request of the patient, and in 71% referral resulted in a change to the patient’s
medication8. The delay before referral illustrates that the ongoing management
of chronic non-cancer pain often rests with community-based service providers,
particularly general practitioners9. In fact, back pain and joint problems together
represent the largest workload of chronic disease seen in the primary care set-
ting10. Therefore, general practitioners are not only the initial point of contact
with healthcare systems, but have a vital role in optimising pain management.
As part of the CHANGE PAIN initiative, a physician survey was conducted
at the 2009 European Federation of IASP Chapters (EFIC) Congress and is still
continuing across Europe. The objective is to gain a better insight into current
pain management, and some results became available at the 3rd International
Conference on Neuropathic Pain in May 201011. Preliminary results indicate
widespread agreement among physicians that pain reduction and improvement
in quality of life are the main treatment goals, making the balance between
efficacy and side-effects a key factor in the choice of analgesic. The majority
of respondents felt there was a limited awareness of the physiological differences
between nociceptive and neuropathic pain in the medical community, but at the
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same time agreed that neuropathic pain was often more
severe and difficult to treat.
A growing trend in healthcare, owing to spiralling costs
and the shortage of providers, is an emphasis on self-man-
agement strategies or group education sessions for patients
with chronic medical conditions12,13. This is very different
from the traditional treatment model centred around
doctor/patient clinic visits. Studies in patients with heart
failure have found that self-management programs
decrease both overall hospital re-admissions and re-admis-
sions for heart failure14, and that patients who did not
adopt these strategies were at high risk of death or
re-admission12. In patients with upper back pain, daily
exercises prescribed by a professional therapist to empha-
sise postural awareness and provide a basic understanding
of the disorder have been shown to be as crucial to reduc-
ing pain and stiffness as hands-on therapy in a clinical
setting15. A related issue is self-medication by patients
with over-the-counter (OTC) drugs, of which the physi-
cian may be unaware. The concern is that readily available
agents such as NSAIDs may present safety issues, espe-
cially in groups such as the elderly frail population, who
may not be properly informed about their use. These are
not benign medications, even at low dosages, so physicians
should routinely ask patients about all forms of self-
medication16.
Another potential answer to the problem of increasing
costs and lack of medically qualified staff could be an
extension of non-medical prescribing, e.g. by nurse pre-
scribers and pharmacists, particularly for special popula-
tions like frail elderly patients. Experience in the UK,
predominantly from primary care, indicates that both
patients and nurse prescribers are generally satisfied with
the practice17, but the continuing professional develop-
ment needs of nurse prescribers are frequently unmet18
and a number of issues relating to the role remain unre-
solved; these include communication systems, clinical
governance and the attitude of other professionals, parti-
cularly the need for support from multidisciplinary
teams19,20.
Pain treatment: less than optimal
One factor that adversely affects pain therapy is poor com-
munication. Successful pain management demands effec-
tive communication between physician and patient, to
achieve a common understanding of the patient’s condi-
tion and expectations, as well as the proposed therapy and
achievable treatment goals. A good understanding reas-
sures patients that the most appropriate analgesic therapy
can be prescribed for their individual requirements.
Effective communication is of particular importance with
respect to the severity of pain, a highly individual experi-
ence, yet there is evidence that significant improvement is
required, not only between physician and patient but also
between healthcare professionals. For example, at the 2009
European Federation of IASP Chapters (EFIC) Congress,
403 respondents were asked to state where they believed
severe pain began on an 11-point Numerical Rating Scale
(NRS); answers mainly ranged from a score of 4 to 811.
This demonstrates a wide variation in the individual inter-
pretation of pain scales, and, therefore, in clinicians’ per-
ception of patients’ experience of pain, potentially
compromising any proposed treatment.
Poor communication between physician and patient
has been demonstrated by a German study in which phy-
sicians and patients separately assessed pain intensity and
pain-dependent impairment during rehabilitation training
in chronic low back pain patients. Only 19.4% of physi-
cians accurately rated patients’ pain-related impairment.
The relevance of adequate pain assessment is highlighted
by the responder rate of 92.3% in this group (see
Figure 1)21.
Consensus point: efficient communication between
physician and patient is crucial for a common under-
standing of chronic pain and its impact – the basis for
adequate pain management.
Management of chronic pain should be tailored to the
individual. However, this treatment currently varies enor-
mously, suggesting that it goes beyond the rational need for
individualised treatment. This is exemplified by huge dif-
ferences in the consumption of analgesics between differ-
ent countries, in terms of both quantity and the type of
agent prescribed. For example, data from the internation-
ally accepted information provider IMS Health
(International Medical Statistics) for 2008 showed that
physicians in northern Europe are much more willing to
prescribe opioids than those in the south and east. Of
respondents to the CHANGE PAIN physician survey at
the 2009 EFIC Conference, 93% stated combination ther-
apy was their main pharmacological strategy for treating
severe chronic low back pain and cited no fewer than 104
different combinations11 (see Figure 2). Thus, there is no
consensus or consistency in physicians’ pharmacological
approach to chronic pain, and it may be concluded that
clinical recommendations and guidelines are having little
influence on treatment22,23, which is probably less than
optimal for some patients24.
The World Health Organization’s three-step pain
ladder was originally developed for treating cancer pain,
but is now also used extensively for non-cancer pain25. It
recommends non-opioid analgesics, weak opioids and
strong opioids for Step I, Step II and Step III, respectively,
depending solely on the intensity of the patient’s pain25.
However, chronic pain is related to multiple physiological
causes or pathways, so it is rational to base pain
Current Medical Research & Opinion Volume 27, Number 2 February 2011
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management decisions not only on the severity of pain, but
also on the underlying mechanisms responsible26. Unless
these mechanisms are addressed, analgesic therapy is likely
to prove ineffective. The tendency then is for the clinician
to increase the dose of analgesics, which increases side-
effects, so the dose is reduced, when pain relief again
becomes inadequate, and so on. A ‘vicious circle’ may
become established where the patient alternates between
poor pain relief and avoidable side-effects7.
Most pain specialists now agree that the balance
between adequate pain relief and acceptable tolerability
is best achieved, with fewest adverse effects, by matching
93% Combination therapy
(104 different combinations mentioned)
7%
50% 0%
4%
4%
ParacetamolAnticonvulsants
Antidepressants
NSAIDS
Fixed combinations of weak opioids
Classical weak opioids
Classical strong oral opioids
Classical strong transdermal opioids
Topical analgesics
Fixed combinations of strong opioids
14%
50%
32%
4%
7%
7%
11%
n = 403
49%
45%29%
Main pharmacological approach to the treatment of severe chronic low back pain
(if combination therapy-maximum 3 analgesic agents)
28%
26%
21%
18%
10%
7% Monotherapy
Figure 2. Variation in pain management strategy (CHANGE PAIN physician survey).
Assessment of pain-related impairment
Responder rate
Physician = Patient
Physician > Patient
Physician < Patient
Physician = Patient
Physician > Patient
Physician < Patient
Physician = Patient: physician estimates pain-related impairment the same as patient
Physician > Patient: physician overestimates pain-related impairment
Physician < Patient: physician underestimates pain-related impairment
0 10 20 30 40 50 60 70
19.4 %
28.4 %
52.2 %
92.3 %
71.7 %
24.3 %
(%)80 90 100
0 10 20 30 40 50 60 70 (%)80 90 100
Figure 1. Differences between physicians’ and patients’ pain assessments: physicians frequently underestimate patients’ pain and impairment.
[From Mueller-Schwefe, 2005].
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the pharmacological action to the causative mechanisms
involved27. This may require combination therapy, since
most commonly available analgesic drugs predominantly
affect a single pain mechanism28. More recent guide-
lines29–31 focus on identifying causative mechanisms in
order to institute the most appropriate treatment, but –
although it is the urgent duty of all concerned with pain
relief to translate new knowledge of pain mechanisms into
improved patient care32 – these have not so far gained
universal acceptance22,23.
Consensus point: successfully treating severe chronic
pain requires balancing analgesia with acceptable tol-
erability, but side-effects may limit the effective dose
that can be tolerated – a vicious circle.
Mechanism-orientated pain treatment
Most pain is multifactorial in nature. Furthermore, the
pain experience can be modulated by the limbic system
and cerebral cortex, acting via a descending transmission
system to produce inhibition or facilitation. Many differ-
ent mechanisms can be involved26, and a better under-
standing of these mechanisms allows a more targeted
approach to the choice of analgesic. This offers advantages
over the conventional practice of grouping patients on the
basis of a common aetiology or disease, which ignores the
fact that a single aetiological factor can produce pain by
diverse mechanisms that may occur singly, sequentially, or
simultaneously26.
Chronic pain (e.g., severe chronic low back pain) may
be predominantly nociceptive, predominantly neuro-
pathic, or a combination of both. Nociceptive pain is
essentially a transient response to a noxious stimulus
such as heat or pressure, and is reversible33, while neuro-
pathic pain is not necessarily associated with a noxious
stimulus and arises from an abnormality of the somatosen-
sory system. This distinction has important clinical impli-
cations because of the different mechanisms involved.
Neuropathic pain (e.g., post-herpetic neuralgia, trigeminal
neuralgia) is associated with more intense and prolonged
pain, more severe co-morbidity and poorer quality of
life34,35, as a result of trophic and structural changes and
central sensitisation36. These patients experience persis-
tent, spontaneous, lancinating pain caused by ectopic dis-
charge, primarily in A fibres, while central sensitisation
may cause hyperalgesia and allodynia33. Recommended
first-line treatments for neuropathic pain include tricyclic
antidepressants and dual reuptake inhibitors of serotonin
and noradrenaline, gabapentin and pregabalin, and topical
lidocaine30. Opioids are generally recommended for
second-line treatment, but can be considered for first-
line use in certain clinical circumstances, such as acute
neuropathic pain or neuropathic cancer pain30. The
early, effective treatment of acute pain is important in
order to prevent its becoming chronic and consequently
more complex to treat.
Ideally, clinicians would be able to identify the specific
causative mechanisms underlying each patient’s symp-
toms, and then prescribe the most appropriate therapy.
For example, N-methyl-d-aspartate (NMDA) receptor
antagonists could be given for the hyperalgesia caused
by central sensitisation, or sodium channel blockers for
the spontaneous pain caused by ectopic discharges37.
However, such identification is difficult in practice,
because one mechanism can produce different symptoms
and one symptom can be produced by different mecha-
nisms38. Nevertheless, clinicians should be aware of the
distinction between nociceptive and neuropathic pain,
the causative mechanisms involved in each, and their con-
tribution to treatment response. This background knowl-
edge will help them to understand their patients’ pain and
guide treatment decisions.
Pain suspected of having several causative mechanisms
should be managed by addressing each of the possible
mechanisms, i.e. by multi-modal analgesia. This may
include both pharmacological and non-pharmacological
therapies such as physiotherapy or neuromodulation – for
example, transcutaneous electrical nerve stimulation
(TENS) or acupuncture. As most analgesic drugs are
mono-modal (have a single mechanism of action), combi-
nations of two or more may often be required simulta-
neously. This offers the potential for lower doses of the
constituent drugs, improved pain relief as a result of addi-
tive or synergistic actions, and less severe adverse effects39.
However, the drugs may exert their effects independently,
or interact to potentiate or antagonise each other, affect-
ing both analgesic efficacy and tolerability. Randomised
controlled trials of a few drug combinations have shown
encouraging results in terms of efficacy, tolerability and
safety, but rigorous supportive evidence is limited and
much more research is required into the wide range of
combinations currently used to treat chronic pain40–42.
Consensus point: pain management decisions should
focus mainly on the underlying mechanisms and not
only on intensity of pain.
To increase understanding of these causative mecha-
nisms, and their importance in achieving effective man-
agement of severe chronic pain, the CHANGE PAIN
initiative involves conducting surveys, analysing pub-
lished data, and communicating the results via electronic
and printed media. This educational remit extends to con-
tinuous medical education (CME). Several interactive
e-learning modules supported by the CHANGE PAIN
group are currently under development by an independent
Current Medical Research & Opinion Volume 27, Number 2 February 2011
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agency, financed by an educational grant from
Gru¨nenthal. The first educational modules, which have
been CME-accredited by the Union Europe´enne Des
Me´de´cins Spe´cialistes (UEMS), cover the following
topics: assessing pain and patient/physician communica-
tion, multi-modal management of chronic pain, and
mechanism-orientated pharmacological pain therapy.
The modules can be accessed via the CHANGE PAIN
website (www.change-pain.com).
The new CHANGE PAIN Scale
The poor management of chronic pain partly results from
clinicians’ inadequate communication and assessment
skills43,44. In a survey of 897 physicians dealing with
cancer patients, 76% cited their own sense of low compe-
tence in patient assessment as the major barrier to effective
pain management45. In addition, all healthcare practi-
tioners exhibit a degree of assessment bias, which can
lead to under-assessment of pain and a disparity between
patients’ and clinicians’ ratings of pain intensity44.
The use of standardised instruments can improve com-
munication between physicians and patients, providing
a greater insight into their pain and an indication of the
level of pain relief they regard as acceptable. This is impor-
tant not only for diagnosis and treatment, but also for its
influence on the attitude of chronic pain patients; one of
the strongest unique predictors of treatment satisfaction is
patients’ belief that their pain has been thoroughly evalu-
ated46. As part of its commitment to improving physician/
patient communication, the CHANGE PAIN group has
produced a simple tool based on the concept of individual
treatment targets (ITTs) developed by G. Mueller-
Schwefe and M.A. Ueberall47. The CHANGE PAIN
Scale can be used quickly and easily in the primary care
setting to record pain intensity, define individualised treat-
ment goals, and provide insight into ways of improving
patients’ quality of life.
Numerous scales exist to measure the severity of pain,
such as the visual analogue scale (VAS), the numeric
rating scale (NRS) and the verbal rating scale (VRS),
with the object of ‘quantifying’ it. Use of these scales is
established in clinical trials and constitutes an effective
means of monitoring changes in pain intensity over
time. Acute pain can be reliably assessed, both at rest
and during movement, by one-dimensional tools such as
the VAS and NRS, but chronic pain assessment and its
impact on physical, emotional and social functions require
multi-dimensional qualitative tools and health-related
quality of life instruments48. A survey conducted in 2003
by Institute TNS Emnid of Bielefeld, Germany, suggested
that fewer than 10% of patients who consult a physician
because of pain are asked to demonstrate the intensity of
their pain using a pain scale, or to complete a pain
questionnaire.
Patients also differ enormously in what they consider to
be an acceptable level of pain; very few expect complete
pain relief and many will be happy with low levels of
chronic pain, but a small proportion will readily tolerate
much higher levels. Identifying these levels is an important
factor in successful pain management. Pain scales can
therefore play a role in establishing individual treatment
targets (ITTs) and measuring patients’ progress towards
them.
To select the most appropriate therapy, physicians
need a clear idea not only of a patient’s level of pain
and ITT, but also of the impact that pain has on the
patient’s quality of life. Several detailed questionnaires
(e.g., Short Form-36/Short Form-12, Western Ontario
and McMaster Universities Osteoarthritis Index, Brief
Pain Inventory) are available to help assess this impact.
They ask questions about the limitation of daily activities,
emotional health, social life and energy levels, in order
to build up an overall picture of the effect of chronic
pain on the patient. Instruments such as pain diaries and
questionnaires may also be used by patients to record their
pain and its effect on their lives. Pain management can be
improved by the detailed documentation of pain and its
effect on quality of life using these methods, but they
are comparatively involved and time-consuming.
Consequently, they are suitable for pain specialists but
rarely used by general practitioners and other primary
care physicians. Thus, there is a requirement for a
simple, user-friendly assessment tool which can be used
in a short consultation and focuses on the most important
aspects of chronic pain, simultaneously directing history-
taking not only towards pain intensity, but also towards
the patient’s quality of life and expectations of treat-
ment, which do not feature in the standard VAS and
NRS scales.
The CHANGE PAIN Scale (see Figure 3) has been
proposed to meet this requirement. The primary care phy-
sician or pain specialist can use it initially to identify the
key elements of successful pain management, and subse-
quently to record patient-centred perception of changes in
well-being. A major design criterion has been ease of use.
The 11-point NRS on the front enables the patient’s cur-
rent pain intensity to be quickly established and a realistic
target level to be set in collaboration with the patient. Six
key parameters that affect patients’ quality of life appear on
the back; these are based on the Brief Pain Inventory and
their importance has been indirectly confirmed by other
studies1. Clinicians simply need to agree with patients
whether and what level of improvement is needed in
each of these. Results at subsequent appointments can be
compared to establish the efficacy and tolerability of the
Current Medical Research & Opinion Volume 27, Number 2 February 2011
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chosen pain management strategy, and the rate of progress
towards patients’ ITTs.
The wider perspective
Better communication and patient assessment skills will
help improve and tailor pain management, but other mea-
sures are also important and these depend upon advances
in medical education. Firstly, a greater emphasis needs to
be placed upon pain management in the medical under-
graduate curriculum. For example, a recent report by the
Pain Education Special Interest Group of the British Pain
Society described the pain education of healthcare under-
graduates in the UK as ‘woefully inadequate’; the median
time spent on pain management by a medical student was
13 hours, with some spending only 6 hours49. Furthermore,
the subject was taught piecemeal, as a part of other topics,
rather than as a discrete module49. Secondly, the focus of
chronic pain education should change from symptom con-
trol to mechanism-based multi-modal pain management.
This approach is endorsed by bodies such as EFIC, which
organises and runs postgraduate courses, supports educa-
tional initiatives, and is working towards pan-European
training and certification standards in pain medicine.
Thirdly, the shift in focus should be accompanied by ini-
tiatives to boost the education of healthcare professionals
on the adequate use of analgesics, non-pharmacological
approaches and encouragement to follow the latest guide-
lines on pain relief.Widespread adoption of these measures
could contribute significantly not only to the alleviation of
individual suffering, but also to reducing the economic
burden of chronic pain and lessening its considerable
impact on healthcare resources.
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